Abstract
The incidence of hepatocellular carcinoma continues to increase worldwide, representing one of the premier causes of cancer-related deaths. It is closely related to liver fibrosis and cirrhosis (and their underlying etiologies), thus making its treatment a challenge, as one has to simultaneously manage both the liver disease, as well as the malignancy. Although there are a variety of different therapies proposed, the two main ones that can actually lead to a therapeutic result, are surgical resection and orthotopic liver transplantation. However, the challenge remains in terms of early diagnosis of the disease, identifying the steps that lead to its progression and choosing the best treatment for each patient. Regarding this latter comment, it has been determined that not all cancers are the same, in the sense that their molecular make-up and alterations are what dictate their specific behavior and aggressiveness; which would be helpful to know if the goal is to choose a patient- and tumor-oriented individualized approach, that will yield better results. Critical in this effort has been and continues to be the role of microRNA, which appears to play a central role in the progression, diagnosis and management of hepatocellular carcinoma. This paper will attempt to clarify the role of microRNA in these areas and provide a window to the future.
Keywords: Biomarkers, hepatocellular carcinoma, microRNA, orthotopic liver transplantation, surgical resection, therapy.
MicroRNA
Title:Role of MicroRNA in the Diagnosis and Therapy of Hepatocellular Carcinoma: A New Frontier
Volume: 3 Issue: 3
Author(s): Georgios Tsoulfas
Affiliation:
Keywords: Biomarkers, hepatocellular carcinoma, microRNA, orthotopic liver transplantation, surgical resection, therapy.
Abstract: The incidence of hepatocellular carcinoma continues to increase worldwide, representing one of the premier causes of cancer-related deaths. It is closely related to liver fibrosis and cirrhosis (and their underlying etiologies), thus making its treatment a challenge, as one has to simultaneously manage both the liver disease, as well as the malignancy. Although there are a variety of different therapies proposed, the two main ones that can actually lead to a therapeutic result, are surgical resection and orthotopic liver transplantation. However, the challenge remains in terms of early diagnosis of the disease, identifying the steps that lead to its progression and choosing the best treatment for each patient. Regarding this latter comment, it has been determined that not all cancers are the same, in the sense that their molecular make-up and alterations are what dictate their specific behavior and aggressiveness; which would be helpful to know if the goal is to choose a patient- and tumor-oriented individualized approach, that will yield better results. Critical in this effort has been and continues to be the role of microRNA, which appears to play a central role in the progression, diagnosis and management of hepatocellular carcinoma. This paper will attempt to clarify the role of microRNA in these areas and provide a window to the future.
Export Options
About this article
Cite this article as:
Tsoulfas Georgios, Role of MicroRNA in the Diagnosis and Therapy of Hepatocellular Carcinoma: A New Frontier, MicroRNA 2014; 3 (3) . https://dx.doi.org/10.2174/2211536604999141222225112
DOI https://dx.doi.org/10.2174/2211536604999141222225112 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pro-inflammatory Cytokines in Animal and Human Gestation
Current Pharmaceutical Design How is Gene Transfection Able to Improve Current Chemotherapy? The Role of Combined Therapy in Cancer Treatment
Current Medicinal Chemistry MicroRNAs in Breast Cancer Therapy
Current Pharmaceutical Design Recent Anticancer Cytotoxic Agents
Current Medicinal Chemistry - Anti-Cancer Agents MicroRNA Therapeutics: the Next Magic Bullet?
Mini-Reviews in Medicinal Chemistry Cytotoxic and Allergenic Potential of Bioactive Proteins and Peptides
Current Pharmaceutical Design Study of Cancer Cell Lines with Fourier Transform Infrared (FTIR)/ Vibrational Absorption (VA) Spectroscopy
Current Physical Chemistry The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems
Current Drug Targets Nanoparticulate Iron Oxide Contrast Agents for Untargeted and Targeted Cardiovascular Magnetic Resonance Imaging
Current Nanoscience Therapeutics Based on microRNA: A New Approach for Liver Cancer
Current Genomics Determinants of Left Ventricular Hypertrophy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Calpains: Attractive Targets for the Development of Synthetic Inhibitors
Current Topics in Medicinal Chemistry Mutations of Chromatin Structure Regulating Genes in Human Malignancies
Current Protein & Peptide Science Bortezomib and Arsenious Acid Synergistically Inhibit HL-60 Cells Viability in vitro and in vivo
Current Signal Transduction Therapy An Update on Extemporaneous Preparation of Radiopharmaceuticals Using Freeze-Dried Cold Kits
Mini-Reviews in Medicinal Chemistry Differential Involvement of Myosin II and VI in the Spontaneous and SDF- 1-induced Migration of Adult CD133+ Hematopoietic Stem/Progenitor Cells and Leukemic Cells
Current Cancer Therapy Reviews Intracellular Calcium, Endothelial Cells and Angiogenesis
Recent Patents on Anti-Cancer Drug Discovery Synthesis and Enzymological Characterization of Some 2-(Substitutedphenylamino) quinazolin-4(3H)-one Derivatives as Potent α-Glucosidase Inhibitors In Vitro
Letters in Drug Design & Discovery Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?
Current Cancer Drug Targets Synthesis and Anti-Proliferative Activity of New Biphenyle-Benzylidenethiazolidine- 2,4-dione Bis-Adducts Containing Various Heterocyclic Cores
Letters in Drug Design & Discovery